Objective: To elucidate the relationships between growth and zinc and iron status in normal infants. Study design: Growth of normal infants (less than 3 y old; n 66) was prospectively assessed with a mean delay of 24 + 6 weeks between measurements; subjects were free from illness and presented with a normal growth. Growth was compared to serum zinc (s-zinc), IGF-1 and iron status. Setting: Teaching hospital of Caen. Results: No relation was found between linear or weight growth and s-zinc; when taking into account the effect of age, linear growth was signi®cantly associated with ferritin (P`0.001); weight gain was signi®cantly correlated with IGF-1 (P 0.034) and ferritin (P 0.008). No relationship was found between s-zinc and iron status. Conclusions: In normal infants iron status, more than serum zinc, seems to be correlated with growth.
Introduction
Among minerals and trace elements, zinc is thought to have the greatest in¯uence on growth. It is the cofactor of several metallo-enzymes involved in protein and nucleic acids synthesis, and increases the synthesis of growth factors such as IGF-1 or growth hormone and their effect on target tissues; major manifestations of zinc de®ciency include retarded growth and development, poor immunity and reduced neurosensory function including hypogeusia, nyctalopia and cognitive de®cits (Thissen et al, 1994; Branda Ïo-Neto et al, 1995; Nishi, 1996) .
Zinc supplementation improves growth and circulating growth factors in growth-retarded children; this effect was displayed in several studies reviewed recently (Nishi, 1996; Ninh et al, 1996; Brown et al, 1998; Kaji et al, 1998) , and is used to con®rm a mild degree of zinc de®ciency.
As with zinc de®ciency, iron de®ciency has been implicated as a cause of stunting, developmental delay, reduced cognition and impaired immunity. Several reports have shown that the correction of iron de®ciency improves growth in stunted children (Aukett et al, 1986; Chwang et al, 1988; Angeles et al, 1993; Vihervuori et al, 1997) .
So far, however, to what extent normal growth is related to iron or zinc status remains to be precisely determined. Iron and zinc share the same digestive transport mechanisms (Conrad et al, 1994; Gunshin et al, 1997) ; in the young animal their competition for digestive absorption results in a decreased zinc storage (Sandstro Èm et al, 1985; Bougle Â et al, 1999; Pe Âre Ás et al, 1999) ; in human a similar metabolic relationship occurs during pharmacological supplementation (Solomons & Ruz, 1997 ), but it is not known if these interactions could be of functional signi®cance in the normal infant. Therefore, this prospective study was designed to assess simultaneously iron and zinc status in healthy, normally grown infants.
Subjects and methods
Infants (less than 3 y-old) were patients attending at the outpatient clinic of the Pediatric department of the university hospital.
All had a normal growth within + 2 s.d. of French charts; infants with current or recent infection or endocrine or digestive disease were excluded. Weight was measured to the nearest 10 g with an electronic beam balance; height was measured twice by the same examiner to the nearest 0.5 cm.
Infants were included if blood had to be drawn (in most cases because an iron de®ciency was suspected) at the second visit, if there was a delay of at least 2 months between these visits, and if no signi®cant illness had occurred during that period. Iron de®ciency was mainly suspected on pallor, fatigability or iron de®ciency previously reported during pregnancy.
Separation of serum from blood was performed within half an hour of taking the sample. Blood cell counts were assayed on a Coulter Counter S890. Serum iron (s-iron) and serum zinc (s-zinc) were measured by atomic absorption spectrometry on a Perkin Elmer 3030 (Pe Âre Ás et al, 1999) . Ferritin concentration was analysed by an immuno-assay (Elecsys, Boehringer Manneim, France), and transferrin by a near-infrared particule immuno-assay (Immage, Beckman, France). IGF-1 was determined by an immuno-assay as previously described (Sabatier et al, 1996) . Growth and biological data were collected for 72 infants; six of them had biological signs of in¯ammation (C reactive protein b 10 or sedimentation rate b 10) and were excluded. The mean delay between the two visits was 24 + 6 weeks. The data of 66 infants were analysed.
In the ®rst step, growth and iron status were compared by an unpaired Student's t-test between infants with low and normal s-zinc. Thereafter, multiple regression analyses, including stepwise regression, were performed, using growth rate (length or weight) as dependent variables and s-zinc, IGF-1 and parameters of iron status and age as independent parameters; they used StatViews for Windows, version 4.5 (Abacus concepts, CA). Power testing of these analysis was performed on GPOWER (Erdfelder et al, 1996) . The level of signi®cance was set at P`0.05. Table 1 presents the results of Student's t-test between subjects whose zinc plasma levels were in the de®cient range (n 14; 21%) compared to the normal subjects: from our laboratory data, the cut-off level of plasma zinc was 12 mmolal (mean À2 s.d.).
Results
Yet the mean age of low and normal s-zinc groups did not differ signi®cantly, multiple regressions between growth rates as dependent variables and age at study and zinc plasma levels as independent variables were performed to take into account the potential effect of age on the growth rate; in the de®cient group, the relationship was signi®cant (P`0.05 and P`0.001 for linear growth and weight gain respectively), but the growth rate was only related to the age (P`0.02; P`0.01) and not to zinc levels; in normal children, the relationship was signi®cant only for the weight gain (P`0.001), which was related to the age (P`0.001) and not to zinc levels. Table 2 displays the relationships between growth parameters and biological data of zinc and iron status in the whole group: height and weight growth rates were signi®-cantly related to age and ferritin, but not to s-zinc; weight gain was also related to IGF-1.
In addition, multiple regression analysis did not display any signi®cant relationship between s-zinc and any parameter of iron status, ie s-iron, ferritinemia, transferrin or transferrin saturation, haemoglobin, haematocrit or MCV.
Discussion
Numerous studies have pointed to the important role of zinc in growth (Branda Ïo-Neto et al, 1995; Nishi, 1996) ; most of them, however, were supplementation trials performed in short, malnourished children (Nishi, 1996; Ninh et al, 1996; Brown et al, 1998) .
Studies on the relationship between iron and growth (Aukett et al, 1986; Chwang et al, 1988; Angeles et al, 1993; Vihervuori et al, 1997; Persson et al, 1998; Scherriff et al, 1999) involved mainly iron de®cient and stunted children (Aukett et al, 1986; Chwang et al, 1988; Angeles et al, 1993; Vihervuori et al, 1997; Perrone et al, 1999) and con®rmed experimental studies (Dhur et al, 1989) . A combined supplementation trial pointed to the potential synergy between iron and zinc effects on growth: it showed that iron is necessary to prime the growth-inducing effect of zinc in case of iron de®ciency (Perrone et al, 1999) .
Our study showed that in normal infants growth is not related to s-zinc but to iron status, as shown by multiple regression analysis; the lower growth rate displayed by infants whose s-zinc levels were in a de®cient range was not explained by s-zinc variations but was in relation to the higher age of these infants. It cannot be excluded, however, that these children could be also zinc de®cient. The absence of signi®cant difference between low and normal s-zinc infants suggests that these groups had in fact a similar nutritional status. Although our study was initially devoted to iron-de®cient infants, the low incidence of iron de®-ciency seems to exclude any bias due to inclusion criteria. The power of our analysis was calculated (Erdfelder et al, 1996) , and this study had only a 20% chance of displaying a statistical effect of s-zinc on growth; however, three parameters explained 67% of the length and weight increment, namely the age, IGF-1 and ferritin. Adding s-zinc to the analysis added less than 0.1% to this value, which could be considered of a negligible clinical interest. In addition no relationship was found between s-IGF-1 and s-zinc or growth rate, nor between s-zinc ad iron status.
s-Zinc is a not an ideal indicator of zinc status because it decreases during sepsis and in¯ammation (Salmenpera È, (Brown, 1998) . Care was taken to discard from the study infants who were suspected of sepsis. On the basis of s-zinc 20% of the infants who were studied were zinc-de®cient. Close values (range 10 ± 20%) were reported in recent studies (Haschke et al, 1986; Favier, 1991; Michaelsen, 1997) and could re¯ect the global prevalence of zinc de®ciency, which is largely unknown . Some higher values were reported which could be explained by the low zinc bioavailability of high-cereal diets (Persson et al, 1998) .
In humans, the relationships between zinc and growth are based mainly on intervention trials in growth-retarded children. Negative correlations are found between two explanatory variables, namely initial growth and s-zinc: children with the greater degree of stunting and the lower s-zinc display the greater catch-up growth during supplementation, as reviewed by Brown et al, (1998) .
In normal infants, s-zinc is associated with growth velocity during periods of rapid growth, and zinc can become a limiting nutrient for tissue synthesis (Michaelsen, 1997) . When basal dietary supply is high and in older infants no correlation is found between s-zinc and growth (Ece et al, 1997) ; zinc supplementation of non-de®cient infants does not increase their growth velocity (Salmenpera È et al, 1994; Ruz et al, 1997) .
Therefore, after the ®rst months of life, in normally growing infants, s-zinc and growth appear to be regulated by independent mechanisms. This assumption is supported by the absence of a signi®cant relationship between IGF-1 and s-zinc. Besides growth hormone, dietary zinc and protein are two of the main determinants of IGF-1 synthesis (Thissen et al, 1994) , which is shown by experimental and human studies of de®cient and supplemented subjects (Branda AEo-Neto et al, 1995; Ninh et al, 1996; Cossack, 1984) . No relationship is found between s-zinc and IGF-1 in children with delayed growth (Mokni et al, 1993) , con®rming that the growth-stimulating effect of zinc is only partially mediated by IGF-1; alternatively zinc regulation of IGF-1 may occur at tissue or at cellular level (Branda AEo-Neto et al, 1995) ; on the other hand IGF-1 levels were positively associated with weight gain but not with linear growth, which could relate to its link with obesity (Gourmelen et al, 1994) .
The variations in iron status were related to normal growth. About 10% of the infants had low storage as assessed by ferritin; previous French and European reports gave similar (Mekki et al, 1989) or lower (Persson et al, 1998; Haschke et al, 1986; Michaelsen, 1997) values in infants. In other studies the higher proportion of infants with depleted iron stores could be explained by the low mineral availability of a cereal-rich diet (Persson et al, 1998) .
Several studies have reported a negative relationship between iron stores and growth (Vihervuori et al, 1997; Persson et al, 1998; Michaelsen, 1997; Anttila et al, 1997) ; this relationship occurs in periods of intense growth, either in the ®rst months of life or during pubertal development, or during the catch-up growth induced by growth hormone substitution, which could exhaust iron stores. It disappears in older infants when growth slows (Scherriff et al, 1999) . The positive effect of iron on growth is emphasized by reports of iron supplementation of stunted and malnourished children (Aukett et al, 1986; Chwang et al, 1988; Angeles et al, 1993; Perrone et al, 1999) .
The results of the present study support the assumption that, even in normal infants, iron status is a limiting factor of growth which could be improved by optimizing iron status.
Competitive interations between iton and zinc are known to occur (Solomons & Ruz, 1997) . They share the same transport mechanism for digestive absorption (Gunshin et al, 1997) . We and other (Haschke et al, 1986; Ece et al, 1997) did not ®nd any relationship between s-zinc and iron stores in the normal infants, con®rming experimental data: within a range of 1:2 ± 2:1, which is close to dietary values, iron and zinc do not compete for absorption (Pe Âre Ás et al, 1999) . On the other hand, a relationship between zinc and iron status can be found when a low mineral bioavailability exacerbates the metabolic need for these trace elements (Persson et al, 1998) .
Conclusion
This short prospective survey of growth rate suggests that, in normal infants, growth is not related to zinc status assessed by its plasma levels, but that iron status could be a limiting factor of growth even in absence of de®-ciency. Further studies are needed to support these assumptions, using more reliable parameters of zinc status when available.
